TY - JOUR T1 - Evaluation of Prostate Cancer with PET/MRI JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 111S LP - 116S DO - 10.2967/jnumed.115.169763 VL - 57 IS - Supplement 3 AU - Liza Lindenberg AU - Mark Ahlman AU - Baris Turkbey AU - Esther Mena AU - Peter Choyke Y1 - 2016/10/01 UR - http://jnm.snmjournals.org/content/57/Supplement_3/111S.abstract N2 - In the ongoing effort to understand and cure prostate cancer, imaging modalities are constantly evolving to assist in clinical decisions. Multiparametric MRI can be used to direct prostate biopsies, improve diagnostic yield, and help clinicians make more accurate decisions. PET is superior in providing biologic information about the cancer and is sensitive and highly specific. Integrated PET/MRI is a welcome technical advance with great potential to influence the diagnosis and management of prostate cancer in clinical practice. ER -